Using Data to Inform CannaHorse Cannabinoid and Terpene Formulations
Medicine relies on data, clinical trials, and research studies to confirm the efficacy of particular approaches and medications used to treat specific medical conditions. Products developed from hemp and cannabis that promote health and well-being should be no different, which is a foundation on which CannaHorse’s approach to cannabinoid medicine is built.
CannaHorse integrates advanced scientific, pharma-grade formulation practices into products designed to promote equine health and well-being.
To inform our product formulations, we have partnered with Strainprint, which uses patient-generated data to identify which cannabinoids and terpenes are most effective for specific medical conditions and their symptoms. As the Endocannabinoid System (ECS) exists in all mammals, this data from human patients transfers directly to how cannabinoids and terpenes interact with the Endocannabinoid Systems of other animals.
Understanding the Complexity of Cannabis and Hemp
Both cannabis and hemp are complex plants, comprised of hundreds of cannabinoids and dozens of terpenes, along with fatty acids, omegas, and other compounds. Cannabis and hemp are unique species of plants in that there are thousands of different cultivars, commonly referred to as strains or varieties, presenting different cannabinoid potencies and terpenoid profiles.
With cannabinoids and terpenes holding beneficial properties unto their own, CannaHorse has isolated the compounds that have data backing their efficacy for specific medical conditions in our product formulations.
CBD and Other Minor Cannabinoids in CannaHorse Products
CBD is increasingly supported by research showing effectiveness for various medical conditions, including anxiety, inflammation, pain, and the overall promotion of health and well-being achieved via homeostasis.
With CBD proving beneficial in almost all treatment contexts, we base all our products on high levels of CBD. We intentionally integrate minor cannabinoids such as CBN (cannabinol) and CBG (cannabigerol) to compliment the CBD in our targeted formulations, engaging The Entourage Effect.
CBN is well known for its sedative properties, often producing a calming effect that contributes to overall mood regulation without an intoxicating effect. CBG is researched for its ability to bring balance, or homeostasis, engaging with the Endocannabinoid System to regulate immune cells that can reduce inflammation. Trace amounts of THC help enact the entourage effect, ideally increasing the effectiveness of all cannabinoids and terpenes within a formulation.
CannaHorse’s oral product Equilibrium is scientifically formulated to provide a customized hemp solution to support a well-balanced metabolic, immune, and wellness profile in your horse. Strainprint data has revealed that the unique combination of CBD, CBG, trace-amounts of THC is beneficial to humans living with anxiety. Furthermore, Strainprint data support that this unique cannabinoid profile is enhanced by the terpenes linalool, myrcene, and limonene. Essentially, while this product is formulated for overall balance in a horse, it does have broader applications and benefits for overall balance, including metabolic, immune, and mental health.
While all CannaHorse’s products are formulated with a specific outcome in mind, each product contains a balance of cannabinoids and terpenes that encourage homeostasis.
Maximizing Cannabinoid and Terpene Science
CannaHorse, along with Strainprint and our Colorado-based hemp producers and extraction and processing partners, make it an intention to leverage existing data and research on cannabinoids and terpenes for our products. Using the available research in our advanced product formulations and engaging in clinical trials, we demonstrate the efficacy of cannabis and hemp, and as a result, further the cannabis research movement as a whole.
Stay informed through our website and social media channels as we release more product formulations that promote equine health and well-being while addressing condition-specific medical issues.